CBI Probe: Biocon denies bribery charges, says it followed due process of law

Biocon Biologics on Tuesday denied allegations of bribery against the company and its officials associated with the approval process of its product Insulin Aspart injection bAspart.

The Bengaluru-headquartered company, in a statement, said it is governed by a strong code of conduct and condemns any acts of corruption and violation of rules by way of offering or paying bribes or undue favours, either directly or indirectly.